Pharmacokinetics of methylphenidate in oral fluid and sweat of a pediatric subject (original) (raw)

Liquid-chromatographic analysis for methylphenidate (Ritalin) in serum

James Swanson

Clinical chemistry, 1979

View PDFchevron_right

Urinary screening for methylphenidate (Ritalin) abuse: a comparison of liquid chromatography–tandem mass spectrometry, gas chromatography–mass spectrometry, and immunoassay methods

Michele Etter

Clinical Biochemistry, 2004

View PDFchevron_right

Determination of methylphenidate and its metabolite ritalinic acid in urine by liquid chromatography/tandem mass spectrometry

Peter George

Journal of Chromatography B, 2012

View PDFchevron_right

Methylphenidate for Treating ADHD: A Naturalistic Clinical Study of Methylphenidate Blood Concentrations in Children and Adults With Optimized Dosage

Maria D Chermá

European journal of drug metabolism and pharmacokinetics, 2016

View PDFchevron_right

Correlation Between Methylphenidate and Ritalinic Acid Concentrations in Oral Fluid and Plasma

Oscar Garcia Algar

Clinical Chemistry, 2010

View PDFchevron_right

Methylphenidate Blood Levels and Therapeutic Response in Children with Attention-Deficit Hyperactivity Disorder I. Effects of Different Dosing Regimens

Wei-wei Chang

Journal of Child and Adolescent Psychopharmacology, 2006

View PDFchevron_right

Development of a physiologically based model to describe the pharmacokinetics of methylphenidate in juvenile and adult humans and nonhuman primates

Christopher Ruark, Merle Paule

PloS one, 2014

View PDFchevron_right

Evolution of stimulants to treat ADHD: transdermal methylphenidate

Mario Gonzalez

Human Psychopharmacology: Clinical and Experimental, 2009

View PDFchevron_right

Simultaneous detection of methylphenidate and its main metabolite, ritalinic acid, in doping control

Jordi Segura

Journal of chromatography. B, Biomedical applications, 1994

View PDFchevron_right

Quantification of methylphenidate in rat, rabbit and dog plasma using a chiral liquid-chromatography/tandem mass spectrometry method

luis ramos

Analytica Chimica Acta, 2002

View PDFchevron_right

Pharmacokinetics of Methylphenidate In Preschoolers With Attention-Deficit/Hyperactivity Disorder

Jonathan Martinez

Journal of Child and …, 2007

View PDFchevron_right

Methylphenidate oral dose plasma concentrations and behavioral response in children

Basalingappa Hungund

Psychopharmacology, 1982

View PDFchevron_right

A dose-ranging study of a methylphenidate transdermal system in children with ADHD

Gregory Fabiano, Andrea Chronis-Tuscano

Journal of the American Academy of Child and Adolescent Psychiatry, 2005

View PDFchevron_right

Heterogeneity in the pharmacodynamics of two long-acting methylphenidate formulations for children with attention deficit/hyperactivity disorder

Pol Van Lier

European Child & Adolescent Psychiatry, 2008

View PDFchevron_right

Simultaneous Determination of Methylphenidate, Amphetamine and their Metabolites in Urine using Direct Injection Liquid Chromatography-Tandem Mass Spectrometry

SUNGILL SUH

Mass Spectrometry Letters

View PDFchevron_right

Variables That Affect the Clinical Use and Abuse of Methylphenidate in the Treatment of ADHD

James Swanson

American Journal of Psychiatry, 2003

View PDFchevron_right

Impairment and deportment responses to different methylphenidate doses in children with ADHD: The MTA titration trial

B. Vitiello, Howard Abikoff, Stephen Hinshaw

Journal of Developmental & Behavioral Pediatrics, 2001

View PDFchevron_right

Usefulness of Sweat Testing for the Detection of Methylphenidate After Fast- and Extended-Release Drug Administration: A Pilot Study

Óscar García-algar

Therapeutic Drug Monitoring, 2010

View PDFchevron_right

Methylphenidate Dosage for Children With ADHD Over Time Under Controlled Conditions: Lessons From the MTA

Howard Abikoff, Stephen Hinshaw

Journal of The American Academy of Child and Adolescent Psychiatry, 2001

View PDFchevron_right

Determination of amphetamine and methylphenidate in exhaled breath of patients undergoing attention-deficit/hyperactivity disorder treatment

Olof Beck

Therapeutic drug monitoring, 2014

View PDFchevron_right

Assessment of Methylphenidate Prescriptions Written for the Treatment of Attention-Deficit/Hyperactivity Disorder

ibrahim topçu

View PDFchevron_right

Methylphenidate Transdermal System in Adults With Past Stimulant Misuse

Karen Hartwell

Journal of Attention Disorders, 2010

View PDFchevron_right